3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
4
Rectal Neoplasms
2
Neoplasms
2
Gastrointestinal Stromal Tumors
2
Solid Malignant Tumors
1
Sarcoma, Ewing
1
Sarcoma
1
Recurrence
1
Piebaldism
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Glioblastoma
1
Disease Progression
1
Cholangiocarcinoma
1
Bone Neoplasms
1
Interventions
Etoposide
30
Carboplatin
29
atezolizumab
17
durvalumab
16
Cisplatin
14
Topotecan
11
Specimen Handling
9
PM 01183
9
Magnetic Resonance Spectroscopy
7
pembrolizumab
6
olaparib
5
berzosertib
4
anlotinib
4
Radiotherapy
4
Nivolumab
4
Irinotecan
4
Drug Therapy
4
tremelimumab
3
toripalimab
3
tislelizumab
3
Paclitaxel
3
Injections
3
Docetaxel
3
Biopsy
3
Bevacizumab
3
AMG 757
3
sacituzumab govitecan
2
monalizumab
2
cabozantinib
2
Temozolomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
regorafenib
×
90 days
×
Clear all
No trials found.